Skip to Content Skip to Content
Articles from Karen Kreeger
Brothers in Arms: Commensal Bacteria Help Fight Viruses, According to Penn Study

Brothers in Arms: Commensal Bacteria Help Fight Viruses, According to Penn Study

Healthy humans harbor an enormous and diverse group of bacteria and other bugs that live within their intestines. These microbial partners provide beneficial aid in multiple ways – from helping digest food to the development of a healthy immune system.

Karen Kreeger

Pancreatic Cancer Can Run but Not Hide From the Immune System, According to Penn Study

Pancreatic Cancer Can Run but Not Hide From the Immune System, According to Penn Study

A study published this week in Cancer Cell from the Perelman School of Medicine and the Abramson Cancer Center at the University of Pennsylvania describes how pancreatic cancer cells produce a protein that attracts immune cells and tricks them into helpin

Karen Kreeger

FDA-approved Drug Makes Established Cancer Vaccine Work Better, Penn Study Finds

FDA-approved Drug Makes Established Cancer Vaccine Work Better, Penn Study Finds

A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 percent, compared to those patients not taking

Karen Kreeger

Block Its Recycling System, and Cancer Kicks the Can, According to New Penn Study

Block Its Recycling System, and Cancer Kicks the Can, According to New Penn Study

All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage in the face of chemotherapy and other treatments.

Karen Kreeger

NSAIDs and Cardiovascular Risk Explained, According to Studies From Penn's Perelman School of Medicine

NSAIDs and Cardiovascular Risk Explained, According to Studies From Penn's Perelman School of Medicine

After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.

Karen Kreeger

Load More